Letter to the Editor

Vaccine

Volumn 20, Issue 29-30, 2002, Pages 3429-3430

  Belshe, Robert B ^a   Couch, Robert B ^b   Glezen, William P ^b   Treanor, John J ^c  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; CHRONIC BRONCHITIS; CLINICAL STUDY; CLINICAL TRIAL; COLD ACCLIMATIZATION; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; GERIATRIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LETTER; META ANALYSIS; POPULATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION; CHILD; COLD; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; NOTE;

ADMINISTRATION, INTRANASAL; CHILD; COLD; HUMANS; INFLUENZA VACCINES; VACCINES, ATTENUATED;

EID: 0037019898     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00374-2     Document Type: Letter

References (6)

1. Beyer W.E.P., Palache A.M., de Jong J.C., Osterhaus A.D.M.E. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systematic antibody response, and vaccine efficacy: a meta-analysis. Vaccine. 20:2002;1340-1353.
2. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P.et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1998;1405-1412.
3. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L.et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr. 136:2000;168-175.
4. Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D.et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine. 18:2000;899-906.
5. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B.et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults. A randomized controlled trial. JAMA. 282:1999;137-144.
6. Cha T.-A., Kao K., Zhao J., Fast P.E., Mendelman P.M., Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J. Clin. Microbiol. 38:2000;839-845.